Sponsored by SYSMEX
By Nilam Patel
Sysmex XN-1000 PR™: Affordable, reliable oncology lab hematology testing platform deliverable today
Distribution sales representatives are embracing the Sysmex XN-1000 PR™ Hematology Analyzer because of its unique ability to meet the growing needs of oncology practices in smaller physician office laboratories and clinics.
“When I come across an oncology practice, I automatically tell the Sysmex story,” stated one representative. “That’s because the XN-1000 PR provides the same XN reliability and technology in a module that is designed for oncology.”
The XN-1000 PR analyzer offers proven, innovative technology (fluorescent flow cytometry) that allows it to deliver the most comprehensive CBC and differential in the hematology diagnostic market. The design of the system offers workflow standardization and scalability without compromising the industry leading reliability and services laboratories have come to know and expect from Sysmex.
Specific XN-1000 PR attributes and advantages include user-definable rules to drive re-run/reflex testing; comprehensive CBC with unique, reportable parameters that include:
- A reportable 6-part differential, which includes immature granulocyte (IG) count.
- NRBC analysis with every CBC.
- Comprehensive reticulocyte panel (reticulocyte count + immature reticulocyte fraction + reticulocyte hemoglobin- RET-He1) to screen and manage patients at risk of anemia.
- Second, more sensitive platelet methodology, to improve PLT count accuracy in the presence of abnormalities.
- Immature platelet fraction (IPF2) to aid clinician in determining the cause of thrombocytopenia.
This story a distribution representative shared really underscores how the XN-1000 PR can impact patient care:
“A lab manager recalled a patient that had a platelet count that was normal, but it looked kind of funny—so they sent it to the hospital where they had a Sysmex XN-1000 PR. Sysmex uses a fluorescent platelet and gave them an answer that was actually very low. And the patient is sitting there waiting the whole time because of this. The results they were getting from their 3-part differential analyzer were not as precise because it only uses one method to measure the platelets. The XN-1000 PR has two methods, and that made the difference.”
Another distribution representative found that smaller oncology labs were very interested in learning more about how a compact system could offer so much – at an attractive price point. And when labs become aware of the attributes of XN-1000 PR and how they would be beneficial to the management of oncology patients, the table is set for a sale.
“It’s a smart replacement to offer oncology clinics that are currently using a 3-part differential analyzer – because they can easily afford to upgrade to a Sysmex XN-1000 PR with advanced clinical parameters.”
A key role to play
As a distribution representative, you can play a key role in helping oncology practices improve outcomes and manage their patients. With healthcare expanding faster than ever before, you are facing a wealth of untapped potential to fuel your success. In addition, the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) will drive even greater acceptance, with providers being reimbursed on the basis of quality and value of care.
XN-1000 PR is a unique hematology analyzer with comprehensive CBC, reportable 6-part differential and advanced clinical parameters; it provides more information for oncology patient management, thereby meeting these criteria for tests performed.
Sysmex has a decades-long legacy of developing innovative and reliable analyzers. Today, we’ve moved well beyond “building better boxes” to create a more holistic, intuitive ecosystem that improves lab operations, promotes better care and enhances patient management practices. Go Beyond a Better Box™ at WWW.SYSMEX.COM/BEYOND to see how Sysmex improves hematology and your customer’s entire lab.
- CPT code for the reticulocyte count (85045) and a separate code for a reticulocyte count + 1 additional retic parameter, which can be either the IRF or RET-He (85046).
NOTE: All billing and reimbursement decisions should be made in conjunction with the laboratory / practice coding and billing departments.
- CPT code for IPF parameter is the same one that is used for reticulated platelets – 85055.
NOTE: All billing and reimbursement decisions should be made in conjunction with the laboratory / practice coding and billing departments.
Nilam Patel, MT(ASCP)SH, is a Sysmex America Senior Product Manager. He is responsible for understanding the needs and applicability of hematology products and solutions within the various customer market segments of North America.